Clinical Trials in Yangjiang, Guangdong
7 recruiting
Showing 1–5 of 5 trials
Recruiting
Phase 4
PPI Infusion Versus Oral Acid Pump Inhibitors for Bleeding Peptic Ulcers
Upper GI BleedingProton Pump Inhibitors
Chinese University of Hong Kong594 enrolled8 locationsNCT05582174
Recruiting
Phase 4
ASPIrin in Reducing Events in Dialysis ( ASPIRED )
CKD (Chronic Kidney Disease) Stage 5D
Guangdong Provincial People's Hospital9,000 enrolled139 locationsNCT04381143
Recruiting
Phase 4
China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)
HypertensionMTHFR 677 CC or CT GenotypeElevated Plasma Homocysteine (Hcy≥10µmol/L)+1 more
Shenzhen Ausa Pharmed Co.,Ltd32,000 enrolled20 locationsNCT04974138
Recruiting
Phase 4
China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype
HypertensionMTHFR 677 TT Genotype
Shenzhen Ausa Pharmed Co.,Ltd24,000 enrolled20 locationsNCT04974151
Recruiting
Not Applicable
Thrombus Aspiration in STEMI Patients With High Thrombus Burden
ST-segment elevation myocardial infarction (STEMI)
Guangdong Provincial People's Hospital3,838 enrolled50 locationsNCT04212494